Atlas Trials

Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer

Clinical trial NCT03101579 · COMPLETED

Trial details

NCT number
NCT03101579
Sponsor
The First Hospital of Jilin University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Leptomeningeal Metastases
Start date
2017-03-01
Primary completion
2018-09-15
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.